Shanghai - Delayed Quote CNY

LBX Pharmacy Chain Joint Stock Company (603883.SS)

Compare
17.39 +0.21 (+1.22%)
At close: December 27 at 3:00:02 PM GMT+8
Loading Chart for 603883.SS
DELL
  • Previous Close 17.18
  • Open 17.16
  • Bid 17.38 x --
  • Ask 17.39 x --
  • Day's Range 16.96 - 17.80
  • 52 Week Range 11.90 - 28.38
  • Volume 20,336,139
  • Avg. Volume 45,035,929
  • Market Cap (intraday) 13.22B
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) 15.67
  • EPS (TTM) 1.11
  • Earnings Date --
  • Forward Dividend & Yield 0.33 (1.90%)
  • Ex-Dividend Date Oct 10, 2024
  • 1y Target Est --

LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.

www.lbxdrugs.com

40,881

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 603883.SS

View More

Performance Overview: 603883.SS

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

603883.SS
20.28%
SSE Composite Index
14.29%

1-Year Return

603883.SS
17.97%
SSE Composite Index
17.29%

3-Year Return

603883.SS
28.72%
SSE Composite Index
6.02%

5-Year Return

603883.SS
27.60%
SSE Composite Index
13.06%

Compare To: 603883.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603883.SS

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    13.22B

  • Enterprise Value

    17.19B

  • Trailing P/E

    15.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    1.90

  • Enterprise Value/Revenue

    0.76

  • Enterprise Value/EBITDA

    11.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.72%

  • Return on Assets (ttm)

    4.14%

  • Return on Equity (ttm)

    13.69%

  • Revenue (ttm)

    22.63B

  • Net Income Avi to Common (ttm)

    842.61M

  • Diluted EPS (ttm)

    1.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.1B

  • Total Debt/Equity (mrq)

    80.46%

  • Levered Free Cash Flow (ttm)

    1.28B

Research Analysis: 603883.SS

View More

People Also Watch